Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen G Ellis

Showing results (181-190 of 252) with videos related to

Pageof 26
Sort By:
JACC. Cardiovascular Interventions|September 24, 2011
Sirolimus-eluting coronary stents in octogenarians: a 1-year analysis of the worldwide e-SELECT RegistryYoung Joon Hong, Myung Ho Jeong, Alexander Abizaid, et al.
European Heart Journal|April 19, 2018
Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trialsHarsh B Golwala, Christopher P Cannon, Ph Gabriel Steg, et al.
European Heart Journal|June 2, 2007
Effect of the polymer-based, paclitaxel-eluting TAXUS Express stent on vascular tissue responses: a volumetric intravascular ultrasound integrated analysis from the TAXUS IV, V, and VI trialsNeil J Weissman, Stephen G Ellis, Eberhard Grube, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 6, 2010
Vascular responses to the multiple overlapped paclitaxel-eluting stents for the treatment of bare-metal in-stent restenotic lesions: angiographic and intravascular ultrasound analysis from the TAXUS-V ISR trialTomomi Koizumi, Peter J Fitzgerald, Yasuhiro Honda, et al.
Circulation|January 28, 2012
Percutaneous coronary intervention in patients with severe aortic stenosis: implications for transcatheter aortic valve replacementSachin S Goel, Shikhar Agarwal, E Murat Tuzcu, et al.
Journal of the American College of Cardiology|April 4, 2006
Two-year outcomes after sirolimus-eluting stent implantation: results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trialGiora Weisz, Martin B Leon, David R Holmes, et al.
Journal of the American College of Cardiology|May 14, 2013
Cause of death within 30 days of percutaneous coronary intervention in an era of mandatory outcome reportingBhuvnesh Aggarwal, Stephen G Ellis, A Michael Lincoff, et al.
JAMA|March 20, 2008
Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular riskTamali Bhattacharyya, Stephen J Nicholls, Eric J Topol, et al.
Circulation. Arrhythmia and Electrophysiology|January 1, 2013
Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillatorEdwin T Zishiri, Sarah Williams, Edmond M Cronin, et al.
Journal of the American College of Cardiology|July 10, 2007
Thrombosis and drug-eluting stents: an objective appraisalDavid R Holmes, Dean J Kereiakes, Warren K Laskey, et al.
Pageof 26

Showing results (181-190 of 252) with videos related to

Sort By:
Pageof 26
JACC. Cardiovascular Interventions|September 24, 2011
Sirolimus-eluting coronary stents in octogenarians: a 1-year analysis of the worldwide e-SELECT RegistryYoung Joon Hong, Myung Ho Jeong, Alexander Abizaid, et al.
European Heart Journal|April 19, 2018
Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trialsHarsh B Golwala, Christopher P Cannon, Ph Gabriel Steg, et al.
European Heart Journal|June 2, 2007
Effect of the polymer-based, paclitaxel-eluting TAXUS Express stent on vascular tissue responses: a volumetric intravascular ultrasound integrated analysis from the TAXUS IV, V, and VI trialsNeil J Weissman, Stephen G Ellis, Eberhard Grube, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|July 6, 2010
Vascular responses to the multiple overlapped paclitaxel-eluting stents for the treatment of bare-metal in-stent restenotic lesions: angiographic and intravascular ultrasound analysis from the TAXUS-V ISR trialTomomi Koizumi, Peter J Fitzgerald, Yasuhiro Honda, et al.
Circulation|January 28, 2012
Percutaneous coronary intervention in patients with severe aortic stenosis: implications for transcatheter aortic valve replacementSachin S Goel, Shikhar Agarwal, E Murat Tuzcu, et al.
Journal of the American College of Cardiology|April 4, 2006
Two-year outcomes after sirolimus-eluting stent implantation: results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trialGiora Weisz, Martin B Leon, David R Holmes, et al.
Journal of the American College of Cardiology|May 14, 2013
Cause of death within 30 days of percutaneous coronary intervention in an era of mandatory outcome reportingBhuvnesh Aggarwal, Stephen G Ellis, A Michael Lincoff, et al.
JAMA|March 20, 2008
Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular riskTamali Bhattacharyya, Stephen J Nicholls, Eric J Topol, et al.
Circulation. Arrhythmia and Electrophysiology|January 1, 2013
Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillatorEdwin T Zishiri, Sarah Williams, Edmond M Cronin, et al.
Journal of the American College of Cardiology|July 10, 2007
Thrombosis and drug-eluting stents: an objective appraisalDavid R Holmes, Dean J Kereiakes, Warren K Laskey, et al.
Pageof 26